An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D – Endpoints News
Endpoints News |
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
Endpoints News A startup that’s hoping to offer psoriasis patients a pill to treat their condition (instead of the standard treatment of steroids or injections) has closed a $19 million round of funding to take two of its programs to the clinic. The company, Escalier … |
BioPharma-Reporter.com |
Fujifilm to make AAVs for Regenxbio gene therapies
BioPharma-Reporter.com Once inside the body the healthy gene payload is delivered to an affected cell’s nucleus where it transcribes its DNA into RNA. This in turn encodes a specific protein that the body was missing and, when the body replicates the cell, it has the … |